Teleflex to split in 2, buy Biotronik assets for $791M among slew of actions

Teleflex, whose shares sank nearly 20% Thursday, will acquire most of Biotronik’s vascular intervention assets. Teleflex also announced a CFO transition.

By Susan Kelly • Feb. 27, 2025

Thermo Fisher to buy Solventum’s purification and filtration unit for $4.1B

Wall Street applauded the deal, sending shares of Solventum, the 3M spinoff, up 10% on Tuesday.

By Susan Kelly • Feb. 25, 2025

Quest to buy Fresenius Medical Care kidney testing assets

The acquisition will add dialysis-related water testing to Quest’s portfolio and position the company to perform the tests and other end-stage kidney disease services for Fresenius Medical Care.

By Nick Paul Taylor • Feb. 25, 2025

FTC retains stricter merger guidelines under Trump

FTC Chair Andrew Ferguson sent a memo to agency staff on Tuesday clarifying that the Biden-era guidelines will remain in place — for now.

By Rebecca Pifer • Feb. 20, 2025

Medtronic buys Nanovis’ nano technology for use in spine implants

Medtronic will use the technology to develop PEEK interbody spine fusion devices that enhance implant fixation.

By Nick Paul Taylor • Feb. 13, 2025

M&A and a separation take center stage in latest earnings season

BD announced it would split from its biosciences and diagnostics unit, while Zimmer Biomet updated investors on its $1.1 billion buy of Paragon 28.

By Susan Kelly • Feb. 10, 2025

Globus to buy Nevro for $250M

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale and orthopedic relationships.

By Elise Reuter • Feb. 6, 2025

Zimmer touts ASC opportunity with Paragon 28 purchase

With the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment will outpace hips and knees.

By Elise Reuter • Feb. 6, 2025

Top medtech trends in 2025: New products and M&A are bright spots, but Trump brings uncertainty

Experts highlighted surgical robotics, artificial intelligence and M&A as top trends this year. However, the Trump administration could create challenges for the industry.

By Ricky Zipp • Jan. 31, 2025

Zimmer to buy Paragon 28 for $1.1B

Needham analysts, who were surprised by the bargain for Paragon 28, said Zimmer may not be done spending.

By Ricky Zipp • Jan. 29, 2025

Stryker to sell spinal implants business

The company named a new CFO and shared an update on its planned Inari Medical acquisition.

By Elise Reuter • Jan. 29, 2025

Philips to sell emergency care business

Investment firm Bridgefield Capital will buy the segment, which includes cardiac resuscitation and emergency care devices, for an undisclosed amount.

By Elise Reuter • Jan. 28, 2025

Intuitive inks deals to sell robots in Italy, Spain and Portugal

Intuitive is buying businesses that distribute its da Vinci and Ion surgical robots to establish a direct presence in Italy, Spain, Portugal, Malta and San Marino.

By Nick Paul Taylor • Jan. 23, 2025

Medtronic inks distribution deal with Contego with option to buy firm

Medtronic will be the exclusive U.S. distributor of Contego Medical’s portfolio, which includes a carotid stent system and thrombectomy devices.

By Ricky Zipp • Jan. 13, 2025

5 medtech trends to watch in 2025

After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued success for pulsed field ablation as trends to watch this year.

By Ricky Zipp • Jan. 9, 2025

Boston Scientific to buy remaining Bolt Medical stake for up to $664M

The deal for Bolt, developer of an intravascular lithotripsy system to treat coronary and peripheral artery disease, continues Boston Scientific’s brisk run of acquisitions.

By Susan Kelly • Jan. 8, 2025

Stryker to buy Inari Medical for nearly $5B

Stryker made several small deals last year but lacked a larger acquisition like its nearly $5 billion proposal for Inari Medical.

By Ricky Zipp • Jan. 6, 2025

Top 10 medtech deals of 2024

Multibillion-dollar buyouts returned last year, led by Johnson & Johnson’s $13.1 billion acquisition of Shockwave Medical.

By Nick Paul Taylor • Jan. 2, 2025

Labcorp closes takeover of Ballad Health outreach laboratory services

Labcorp continued its streak of hospital lab purchases with a deal that will expand its testing capabilities to communities in Tennessee, Virginia, North Carolina and Kentucky.

By Nick Paul Taylor • Dec. 12, 2024

Patterson, a dental products distributor, agrees to $4.1B sale to healthcare investor

Last week, Patterson Companies announced it would seek strategic alternatives after the company’s profit decreased by one-third in its fiscal second quarter.

By Elise Reuter • Dec. 11, 2024

How Trump’s second term will affect the medtech industry

From M&A and tariffs to new health leaders, here are the top issues for the medtech industry to watch during President Donald Trump’s return to office.

By Ricky Zipp • Dec. 10, 2024

Haemonetics to offload whole-blood business for up to $67M

Selling the assets to Italy’s GVS should help Haemonetics improve its revenue growth and profit margins, analysts said.

By Susan Kelly • Dec. 4, 2024

GE Healthcare to buy radiopharmaceutical firm Nihon Medi-Physics

GE Healthcare has identified radiopharmaceuticals as a growth driver for the company and Japan as a key market.

By Elise Reuter • Dec. 3, 2024

Boston Scientific to buy Intera Oncology, maker of liver cancer treatment

Intera makes a pump and a chemotherapy drug to treat liver tumors. Boston Scientific sees the purchase as a way to provide more comprehensive cancer treatments.

By Elise Reuter • Nov. 25, 2024

Medtronic buys surgical instrument developer Fortimedix

Fortimedix develops flexible surgical instruments that are responsive enough to navigate the body and enable endoscopic and minimally invasive procedures.

By Nick Paul Taylor • Nov. 22, 2024